Here comes the judge

The drug, called Leniolisib, is the first and only treatment approved in the United States for APDS, a rare primary immunodeficiency.

This special Over the Counter episode, brought to you by Total Pharmacy® and Omega Pharmacy Group, dives into how to navigate the business of independent pharmacy and get ahead of key policy changes.

Regulatory officials said additional requirements are needed in order to approve the drug, which is under review for treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease.

In part 1 of our podcast series with American Associated Pharmacies (AAP), AAP President and CEO Jon Copeland dives into key pharmacy industry trends.

Evkeeza, which treats a rare form of high cholesterol, is now approved for patients as young of 5 years.

Stipulations of the settlements include data reporting, annual training, and an independent compliance officer.